Strand Life Sciences has entered into an agreement with the FDA to deliver the Genomics Reviewer Desktop (GRD), a solution to enable FDA reviewers to manage and analyze pharmacogenomic data submitted through its Voluntary Exploratory Data Submissions (VXDS) program.
Available from Dorton Analytical the ultra-sensitive, universal Nano Quantity Analyte Detector (NQAD) presents a major advancement in high performance liquid chromatography detection capability.
SIOGEN Biotech, a leader in silicon-based nanoparticle drug delivery and targeting, and Veeda Clinical Research, a global clinical research organisation, signed a strategic partnership agreement at the BIO conference in Chicago to develop a new nanoparticle formulation of doxorubicin to treat cancer.
The Royal Government of Bhutan, Merck and the Australian Cervical Cancer Foundation (ACCF) launched a national vaccination program with GARDASIL for appropriate girls and young women in Bhutan.
The Food and Drug Administration has approved a novel birth control pill from Bayer Healthcare that combines two female hormones.
A new study by researchers at the Swedish medical university Karolinska Institutet shows that the immune defence's T cells can attack the "bad" LDL cholesterol and thereby cause an inflammation that leads to atherosclerosis.
Chronic pain severely limits patients' quality of life and is among the cost drivers in U.S. health care. Patients can suffer pain without an apparent cause and often fail to respond to available treatments.
With thousands of scientists across the globe searching for ways to use adult stem cells to fight disease, there's a growing emphasis on finding the "master regulators" that guide the differentiation of stem cells.
While previous research had suggested that drinking milk was related to factors that may increase the risk of renal cell cancer, results of a recent study exploiting the genetic contribution to variation in milk consumption suggest that this may not be the case.
Stem cells derived from the endometrium (uterine lining) and transplanted into the brains of laboratory mice with Parkinson's disease appear to restore functioning of brain cells damaged by the disease, according to a new study by Yale School of Medicine researchers.
After menopause, 6 to 10 million women take hormone therapies, which are often a combination of estrogen and progestin, to replace hormones lost from inactive ovaries. Progestin is a hormone that is used to counteract the potentially negative effects of estrogen therapy on the uterus.
Research from the University of Leeds has identified how the virus which causes Kaposi's Sarcoma replicates and spreads – opening a door to a possible new treatment for the disease.
A push to regulate Colorado's medical marijuana dispensaries appears to be nearing the finish line.
A world without "the pill" is unimaginable to many young women who now use it to treat acne, skip periods, improve mood and, of course, prevent pregnancy. They might be surprised to learn that U.S. officials announcing approval of the world's first oral contraceptive were uncomfortable.